TuHURA Biosciences Celebrates Skin Pharm's New Chicago Clinic Launch and Midwest Expansion
- Skin Pharm opens its first Midwest clinic in Chicago on October 9, 2025, expanding its reach in aesthetic care.
- The Chicago clinic offers personalized services and reinforces Skin Pharm's commitment to expert-led skin health solutions.
- This expansion aligns with Skin Pharm's mission to empower clients and meet the growing demand for customized skin care.
Skin Pharm Expands Its Reach with New Chicago Clinic
Skin Pharm, a Nashville-based beauty brand known for its aesthetic skin care clinics and medical-grade products, announces the opening of its fourteenth clinic in Chicago, Illinois, on October 9, 2025. Situated in the bustling Fulton Market area at 345 N Morgan, this location marks Skin Pharm's first venture into the Midwest. The new clinic aims to serve a sophisticated clientele by offering a variety of services, including skin care consultations, injectables, and the brand's signature Gold Infusion treatment. All services are provided by advanced practice providers, underscoring the brand's commitment to delivering expert care to its clients.
The establishment of the Chicago clinic aligns with Skin Pharm's mission to provide personalized and patient-centered aesthetic services. Founded in 2017 by nurse practitioner Maegan Griffin, Skin Pharm was born from a vision to create a clinic environment that prioritizes patient experience and skin health. Griffin expresses enthusiasm about entering the Chicago market, noting the city’s dedication to wellness and its alignment with Skin Pharm's core values. This expansion not only amplifies the brand's presence in the beauty industry but also meets the rising demand for customized skin care solutions across the United States.
The design of the new clinic reflects Skin Pharm's ethos of creating a welcoming and contemporary environment. Interior designer Mrs. Paranjape incorporates a warm color palette of soft greens and natural wood tones, resulting in an inviting space for clients. In addition to in-clinic treatments, customers can access Skin Pharm's award-winning product range—including cleansers, serums, and moisturizers—either in-store or online. The Chicago clinic represents a pivotal moment for Skin Pharm, reinforcing its dedication to enhancing skin health and confidence while catering to the evolving needs of its clientele.
In addition to its expansion, Skin Pharm's focus on quality and personalized care positions it well within the competitive beauty industry. The brand’s commitment to expert-led services and a holistic approach to skin health resonates with a growing audience seeking tailored solutions. As Skin Pharm continues to grow, it maintains its vision of empowering individuals to feel confident in their own skin, which remains a driving force behind its operations.
As the demand for aesthetic treatments rises, Skin Pharm's new Chicago location signifies a strategic move to tap into a burgeoning market. With an established reputation in the South, the brand is poised to make a significant impact in the Midwest, further solidifying its status as a leader in the aesthetic skin care industry.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

